Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 176 of 176 entries
Sorted by: Best Match Show Resources per page
Multi-omics profiling predicts allograft function after lung transplantation.

The European respiratory journal

Watzenböck ML, Gorki AD, Quattrone F, Gawish R, Schwarz S, Lambers C, Jaksch P, Lakovits K, Zahalka S, Rahimi N, Starkl P, Symmank D, Artner T, Pattaroni C, Fortelny N, Klavins K, Frommlet F, Marsland BJ, Hoetzenecker K, Widder S, Knapp S.
PMID: 34244315
Eur Respir J. 2021 Jul 08; doi: 10.1183/13993003.03292-2020. Epub 2021 Jul 08.

RATIONALE: Lung transplantation is the ultimate treatment option for patients with end-stage respiratory diseases but bears the highest mortality rate among all solid organ transplantations due to chronic lung allograft dysfunction (CLAD). The mechanisms leading to CLAD remain elusive...

Cite
Watzenböck ML, Gorki AD, Quattrone F, et al. Multi-omics profiling predicts allograft function after lung transplantation. Eur Respir J. 2021;doi: 10.1183/13993003.03292-2020.
Watzenböck, M. L., Gorki, A. D., Quattrone, F., Gawish, R., Schwarz, S., Lambers, C., Jaksch, P., Lakovits, K., Zahalka, S., Rahimi, N., Starkl, P., Symmank, D., Artner, T., Pattaroni, C., Fortelny, N., Klavins, K., Frommlet, F., Marsland, B. J., Hoetzenecker, K., Widder, S., & Knapp, S. (2021). Multi-omics profiling predicts allograft function after lung transplantation. The European respiratory journal, . https://doi.org/10.1183/13993003.03292-2020
Watzenböck, Martin L, et al. "Multi-omics profiling predicts allograft function after lung transplantation." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.03292-2020
Watzenböck ML, Gorki AD, Quattrone F, Gawish R, Schwarz S, Lambers C, Jaksch P, Lakovits K, Zahalka S, Rahimi N, Starkl P, Symmank D, Artner T, Pattaroni C, Fortelny N, Klavins K, Frommlet F, Marsland BJ, Hoetzenecker K, Widder S, Knapp S. Multi-omics profiling predicts allograft function after lung transplantation. Eur Respir J. 2021 Jul 08; doi: 10.1183/13993003.03292-2020. Epub 2021 Jul 08. PMID: 34244315.
Copy Download .nbib Format: NLM
Identification of Novel Neurocircuitry Through Which Leptin Targets Multiple Inputs to the Dopamine System to Reduce Food Reward Seeking.

Biological psychiatry

Omrani A, de Vrind VAJ, Lodder B, Stoltenborg I, Kooij K, Wolterink-Donselaar IG, Luijendijk-Berg MCM, Garner KM, Van't Sant LJ, Rozeboom A, Dickson SL, Meye FJ, Adan RAH.
PMID: 33867112
Biol Psychiatry. 2021 Dec 15;90(12):843-852. doi: 10.1016/j.biopsych.2021.02.017. Epub 2021 Feb 23.

BACKGROUND: Leptin reduces the motivation to obtain food by modulating activity of the mesolimbic dopamine (DA) system upon presentation of cues that predict a food reward. Although leptin directly reduces the activity of ventral tegmental area (VTA) DA neurons,...

Cite
Omrani A, de Vrind VAJ, Lodder B, et al. Identification of Novel Neurocircuitry Through Which Leptin Targets Multiple Inputs to the Dopamine System to Reduce Food Reward Seeking. Biol Psychiatry. 2021;90(12):843-852doi: 10.1016/j.biopsych.2021.02.017.
Omrani, A., de Vrind, V. A. J., Lodder, B., Stoltenborg, I., Kooij, K., Wolterink-Donselaar, I. G., Luijendijk-Berg, M. C. M., Garner, K. M., Van't Sant, L. J., Rozeboom, A., Dickson, S. L., Meye, F. J., & Adan, R. A. H. (2021). Identification of Novel Neurocircuitry Through Which Leptin Targets Multiple Inputs to the Dopamine System to Reduce Food Reward Seeking. Biological psychiatry, 90(12), 843-852. https://doi.org/10.1016/j.biopsych.2021.02.017
Omrani, Azar, et al. "Identification of Novel Neurocircuitry Through Which Leptin Targets Multiple Inputs to the Dopamine System to Reduce Food Reward Seeking." Biological psychiatry vol. 90,12 (2021): 843-852. doi: https://doi.org/10.1016/j.biopsych.2021.02.017
Omrani A, de Vrind VAJ, Lodder B, Stoltenborg I, Kooij K, Wolterink-Donselaar IG, Luijendijk-Berg MCM, Garner KM, Van't Sant LJ, Rozeboom A, Dickson SL, Meye FJ, Adan RAH. Identification of Novel Neurocircuitry Through Which Leptin Targets Multiple Inputs to the Dopamine System to Reduce Food Reward Seeking. Biol Psychiatry. 2021 Dec 15;90(12):843-852. doi: 10.1016/j.biopsych.2021.02.017. Epub 2021 Feb 23. PMID: 33867112.
Copy Download .nbib Format: NLM
Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands.

Complementary therapies in medicine

Kristoffersen AE, van der Werf ET, Stub T, Musial F, Wider B, Jong MC, Wode K, Danell JB, Busch M, Hoenders HJR, Nordberg JH.
PMID: 34826590
Complement Ther Med. 2021 Nov 23;64:102792. doi: 10.1016/j.ctim.2021.102792. Epub 2021 Nov 23.

OBJECTIVES: The present study was initiated to determine consultations with health care providers and use of self-management strategies for prevention or treatment of COVID-19 related symptoms in countries with a full lockdown (Norway), a partial lockdown (the Netherlands) and...

Cite
Kristoffersen AE, van der Werf ET, Stub T, et al. Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands. Complement Ther Med. 2021;64:102792doi: 10.1016/j.ctim.2021.102792.
Kristoffersen, A. E., van der Werf, E. T., Stub, T., Musial, F., Wider, B., Jong, M. C., Wode, K., Danell, J. B., Busch, M., Hoenders, H. J. R., & Nordberg, J. H. (2021). Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands. Complementary therapies in medicine, 64102792. https://doi.org/10.1016/j.ctim.2021.102792
Kristoffersen, Agnete E, et al. "Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands." Complementary therapies in medicine vol. 64 (2021): 102792. doi: https://doi.org/10.1016/j.ctim.2021.102792
Kristoffersen AE, van der Werf ET, Stub T, Musial F, Wider B, Jong MC, Wode K, Danell JB, Busch M, Hoenders HJR, Nordberg JH. Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands. Complement Ther Med. 2021 Nov 23;64:102792. doi: 10.1016/j.ctim.2021.102792. Epub 2021 Nov 23. PMID: 34826590; PMCID: PMC8609665.
Copy Download .nbib Format: NLM
[Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version].

HNO

Sievert M, Goncalves M, Binder B, Mueller SK, Rupp R, Koch M, Dürr S, Traxdorf M, Hecht M, Iro H, Gostian AO.
PMID: 33837444
HNO. 2022 Jan;70(1):44-50. doi: 10.1007/s00106-021-01029-w. Epub 2021 Apr 09.

BACKGROUND: Recurrent and residual laryngeal cancer after organ-preserving radio- or radiochemotherapy is associated with a poor prognosis. Salvage surgery is the most important therapeutic option in these cases.OBJECTIVE: The study assessed rates of recurrence and residual tumor as well...

Cite
Sievert M, Goncalves M, Binder B, et al. Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO. 2021;70(1):44-50doi: 10.1007/s00106-021-01029-w.
Sievert, M., Goncalves, M., Binder, B., Mueller, S. K., Rupp, R., Koch, M., Dürr, S., Traxdorf, M., Hecht, M., Iro, H., & Gostian, A. O. (2022). Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO, 70(1), 44-50. https://doi.org/10.1007/s00106-021-01029-w
Sievert, Matti, et al. "Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung." [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO vol. 70,1 (2022): 44-50. doi: https://doi.org/10.1007/s00106-021-01029-w
Sievert M, Goncalves M, Binder B, Mueller SK, Rupp R, Koch M, Dürr S, Traxdorf M, Hecht M, Iro H, Gostian AO. Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO. 2022 Jan;70(1):44-50. doi: 10.1007/s00106-021-01029-w. Epub 2021 Apr 09. German. PMID: 33837444.
Copy Download .nbib Format: NLM
A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum.

Journal of vascular surgery. Venous and lymphatic disorders

Bernhard SM, Adam L, Atef H, Häberli D, Bramer WM, Minder B, Döring Y, Laine JE, Muka T, Rössler J, Baumgartner I.
PMID: 34358672
J Vasc Surg Venous Lymphat Disord. 2021 Aug 03; doi: 10.1016/j.jvsv.2021.07.008. Epub 2021 Aug 03.

BACKGROUND: PIK3CA (activating mutations of the p110α subunit of phosphatidylinositol 3-kinases)-related overgrowth spectrums (PROS) include a variety of clinical presentations that are associated with hypertrophy of different parts of the body. We performed a systematic literature review to assess...

Cite
Bernhard SM, Adam L, Atef H, et al. A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum. J Vasc Surg Venous Lymphat Disord. 2021;doi: 10.1016/j.jvsv.2021.07.008.
Bernhard, S. M., Adam, L., Atef, H., Häberli, D., Bramer, W. M., Minder, B., Döring, Y., Laine, J. E., Muka, T., Rössler, J., & Baumgartner, I. (2021). A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum. Journal of vascular surgery. Venous and lymphatic disorders, . https://doi.org/10.1016/j.jvsv.2021.07.008
Bernhard, Sarah M, et al. "A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum." Journal of vascular surgery. Venous and lymphatic disorders vol. (2021). doi: https://doi.org/10.1016/j.jvsv.2021.07.008
Bernhard SM, Adam L, Atef H, Häberli D, Bramer WM, Minder B, Döring Y, Laine JE, Muka T, Rössler J, Baumgartner I. A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum. J Vasc Surg Venous Lymphat Disord. 2021 Aug 03; doi: 10.1016/j.jvsv.2021.07.008. Epub 2021 Aug 03. PMID: 34358672.
Copy Download .nbib Format: NLM
Management of vascular trauma across Canada: A cohort study with implications for practice.

Injury

Smith S, Allen L, Khwaja K, Joos E, Ball CG, Engels PT, Naji F, Lampron J, Widder S, Minor S, Jessula S, Parry NG, Vogt KN.
PMID: 35012752
Injury. 2022 Jan 02; doi: 10.1016/j.injury.2021.12.052. Epub 2022 Jan 02.

BACKGROUND: The aim of this study was to provide a description of vascular trauma and its management at trauma centers across Canada.METHODS: This retrospective cohort study evaluated patients from 8 Canadian level 1 trauma centers (2011-2015). Medical records were...

Cite
Smith S, Allen L, Khwaja K, et al. Management of vascular trauma across Canada: A cohort study with implications for practice. Injury. 2022;doi: 10.1016/j.injury.2021.12.052.
Smith, S., Allen, L., Khwaja, K., Joos, E., Ball, C. G., Engels, P. T., Naji, F., Lampron, J., Widder, S., Minor, S., Jessula, S., Parry, N. G., & Vogt, K. N. (2022). Management of vascular trauma across Canada: A cohort study with implications for practice. Injury, . https://doi.org/10.1016/j.injury.2021.12.052
Smith, Shane, et al. "Management of vascular trauma across Canada: A cohort study with implications for practice." Injury vol. (2022). doi: https://doi.org/10.1016/j.injury.2021.12.052
Smith S, Allen L, Khwaja K, Joos E, Ball CG, Engels PT, Naji F, Lampron J, Widder S, Minor S, Jessula S, Parry NG, Vogt KN. Management of vascular trauma across Canada: A cohort study with implications for practice. Injury. 2022 Jan 02; doi: 10.1016/j.injury.2021.12.052. Epub 2022 Jan 02. PMID: 35012752.
Copy Download .nbib Format: NLM
The neurological level of spinal cord injury and cardiovascular risk factors: a systematic review and meta-analysis.

Spinal cord

Raguindin PF, Fränkl G, Itodo OA, Bertolo A, Zeh RM, Capossela S, Minder B, Stoyanov J, Stucki G, Franco OH, Muka T, Glisic M.
PMID: 34417550
Spinal Cord. 2021 Nov;59(11):1135-1145. doi: 10.1038/s41393-021-00678-6. Epub 2021 Aug 20.

STUDY DESIGN: Systematic review and meta-analysis.OBJECTIVE: To determine the difference in cardiovascular risk factors (blood pressure, lipid profile, and markers of glucose metabolism and inflammation) according to the neurological level of spinal cord injury (SCI).METHODS: We searched 5 electronic...

Cite
Raguindin PF, Fränkl G, Itodo OA, et al. The neurological level of spinal cord injury and cardiovascular risk factors: a systematic review and meta-analysis. Spinal Cord. 2021;59(11):1135-1145doi: 10.1038/s41393-021-00678-6.
Raguindin, P. F., Fränkl, G., Itodo, O. A., Bertolo, A., Zeh, R. M., Capossela, S., Minder, B., Stoyanov, J., Stucki, G., Franco, O. H., Muka, T., & Glisic, M. (2021). The neurological level of spinal cord injury and cardiovascular risk factors: a systematic review and meta-analysis. Spinal cord, 59(11), 1135-1145. https://doi.org/10.1038/s41393-021-00678-6
Raguindin, Peter Francis, et al. "The neurological level of spinal cord injury and cardiovascular risk factors: a systematic review and meta-analysis." Spinal cord vol. 59,11 (2021): 1135-1145. doi: https://doi.org/10.1038/s41393-021-00678-6
Raguindin PF, Fränkl G, Itodo OA, Bertolo A, Zeh RM, Capossela S, Minder B, Stoyanov J, Stucki G, Franco OH, Muka T, Glisic M. The neurological level of spinal cord injury and cardiovascular risk factors: a systematic review and meta-analysis. Spinal Cord. 2021 Nov;59(11):1135-1145. doi: 10.1038/s41393-021-00678-6. Epub 2021 Aug 20. PMID: 34417550; PMCID: PMC8560636.
Copy Download .nbib Format: NLM
Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma.

European journal of gastroenterology & hepatology

Sturm L, Muller L, Schultheiss M, Binder B, Huber JP, Thimme R, Bettinger D.
PMID: 33323760
Eur J Gastroenterol Hepatol. 2020 Dec 14; doi: 10.1097/MEG.0000000000002018. Epub 2020 Dec 14.

BACKGROUND AND AIMS: Several studies have reported associations of proton pump inhibitor (PPI) treatment with the incidence of complications and even increased mortality in patients with liver cirrhosis. Up to now, there are no studies on the impact of...

Cite
Sturm L, Muller L, Schultheiss M, et al. Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2020;doi: 10.1097/MEG.0000000000002018.
Sturm, L., Muller, L., Schultheiss, M., Binder, B., Huber, J. P., Thimme, R., & Bettinger, D. (2020). Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. European journal of gastroenterology & hepatology, . https://doi.org/10.1097/MEG.0000000000002018
Sturm, Lukas, et al. "Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma." European journal of gastroenterology & hepatology vol. (2020). doi: https://doi.org/10.1097/MEG.0000000000002018
Sturm L, Muller L, Schultheiss M, Binder B, Huber JP, Thimme R, Bettinger D. Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2020 Dec 14; doi: 10.1097/MEG.0000000000002018. Epub 2020 Dec 14. PMID: 33323760.
Copy Download .nbib Format: NLM
Showing 169 to 176 of 176 entries